Effects of Internet-Based Neuromuscular Versus Quadriceps Exercise on Pain and Function in Patients With Knee Osteoarthritis: A Single-Blind Randomized Controlled Trial
- Journal
- Journal of evidence-based medicine (Q1)
- Published
- 7 September 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Haiming Wang, Lin Wang, Xiaona Xiang, Chengsen Jia, Chengqi He
- PMID
- 42703695
- DOI
- 10.1111/jebm.70187
Why clinicians should know about it
- Picked for Orthopedics and Sports Medicine (top studies of the week, 1 November 2026): Internet‑based neuromuscular vs quadriceps exercise for KOA
Abstract
BACKGROUND: Exercise and self-management are first-line for knee osteoarthritis (KOA), but evidence on internet-based telerehabilitation comparing specific exercises is limited. We compared a 12-week internet-based neuromuscular exercise (NE) program and a quadriceps exercise (QE) program in community-dwelling patients with symptomatic KOA. METHODS: This single-center, single-blind randomized trial compared 12-week internet-based NE versus QE in community-dwelling adults with symptomatic KOA. The primary outcome: the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain. SECONDARY OUTCOMES: WOMAC function, daily activity, pressure pain threshold, self-efficacy, Timed Up and Go, and 6-Min Walk Test. Subjective outcomes were assessed at 0, 6, 12 weeks; objective outcomes were assessed at 0, 12 weeks. Generalized estimating equations with group, time, and group-by-time terms were used for intention-to-treat analyses, adjusted for age, sex, body mass index, and the baseline value. RESULTS: Of 74 randomized participants (NE = 37, QE = 37), 62 completed the 12-week assessment (16.2% discontinued; 18.9% in the NE group, 13.5% in the QE group). Enrollment was below the planned 53 participants per group. At 12 weeks, the adjusted between-group difference in WOMAC pain change was -1.0 points (95% confidence interval [CI], -2.4 to 0.4; p = 0.150; Cohen's d = -0.34); at 6 weeks, it was -0.8 points (95% CI, -1.9 to 0.4; p = 0.188; Cohen's d = -0.33). No statistically significant between-group differences were found in secondary outcomes. CONCLUSIONS: This under-enrolled trial found no significant difference between NE and QE in WOMAC pain at 12 weeks. Both groups showed within-group improvement, but equivalence was not established. Findings should be interpreted cautiously due to limited statistical power.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.